Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Ltd: No Mandatory Borrowing Required for FY 2025-26 📊

- Oxygenta Pharmaceutical Ltd is not classified as a Large Corporate under SEBI Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023

- The company reported no mandatory borrowing through debt securities for the financial year 2025-26, with actual borrowing recorded as nil

- No shortfall in mandatory borrowing or penalty applies for the block period FY 2025-26 and FY 2026-27